GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IDXG
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Interpace Diagnostics Group stock price ended at $1.45 on Friday, after losing 1.36%.
(Updated on Apr 19, 2024)

Buy or Hold candidate since Apr 15, 2024 Loss -1.36% PDF

The Interpace Diagnostics Group stock price fell by -1.36% on the last day (Friday, 19th Apr 2024) from $1.47 to $1.45. During the last trading day the stock fluctuated 2.11% from a day low at $1.42 to a day high of $1.45. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks. Volume has increased on the last day by 7 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 7 thousand shares were bought and sold for approximately $9.44 thousand.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.40 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 49.32% during the next 3 months and, with a 90% probability hold a price between $2.08 and $3.07 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IDXG Signals & Forecast

There are mixed signals in the stock today. The Interpace Diagnostics Group stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.49. On a fall, the stock will find some support from the short-term average at $1.44. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Monday, March 11, 2024, and so far it has fallen -17.14%. Further fall is indicated until a new bottom pivot has been found. Interpace Diagnostics Group gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Interpace Diagnostics Group stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.35 and $1.20. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Interpace Diagnostics Group finds support just below today's level at $1.35. If this is broken, then the next support from accumulated volume will be at $1.20 and $1.10.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0300 between high and low, or 2.11%. For the last week, the stock has had daily average volatility of 3.03%.

Our recommended stop-loss: $1.38 (-4.86%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 28 days ago.)

Trading Expectations (IDXG) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Interpace Diagnostics Group to open at $1.44, and during the day (based on 14 day Average True Range), to move between $1.33 and $1.57, which gives a possible trading interval of +/-$0.121 (+/-8.36%) up or down from last closing price. If Interpace Diagnostics Group takes out the full calculated possible swing range there will be an estimated 16.72% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.50 (3.45%) than the support at $1.35 (6.90%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Interpace Diagnostics Group stock A Buy?

Interpace Diagnostics Group holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Interpace Diagnostics Group of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$1.44 ( 0.690%) $1.45

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IDXG

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.47 1.38 %
R2 1.46 0.589 %
R1 1.45 0.101 %
Current price: 1.45
Support S1 1.43 -1.48 %
S2 1.42 -1.97 %
S3 1.41 -2.76 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.66 14.48 %
R2 1.63 12.41 %
R1 1.50 3.45 %
Current price 1.45
Support S1 1.35 -6.90%
S2 1.20 -17.24%
S3 1.10 -24.14%

FAQ

What is the symbol for Interpace Diagnostics Group Stock and on which exchange is it traded?
The symbol for Interpace Diagnostics Group is IDXG and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Interpace Diagnostics Group Stock?
Interpace Diagnostics Group holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Interpace Diagnostics Group Stock?
Interpace Diagnostics Group Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Interpace Diagnostics Group Stock.

What's the current price of Interpace Diagnostics Group Stock?
As of the end of day on the 2024-04-19, the price of an Interpace Diagnostics Group (IDXG) share was $1.45.

What is the 52-week high and low for Interpace Diagnostics Group Stock?
The 52-week high for Interpace Diagnostics Group Stock is $3.54 and the 52-week low is $0.620.

What is the market capitalization of Interpace Diagnostics Group Stock?
As of the 2024-04-19, the market capitalization of Interpace Diagnostics Group is 6.433M.

When is the next earnings date for Interpace Diagnostics Group?
The upcoming earnings date for Interpace Diagnostics Group is May 10, 2024.
Click to get the best stock tips daily for free!

About Interpace Diagnostics Group

Interpace Diagnostics Group Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; PanDNA, a molecular only version of PancraGEN that provides physicians a snapshot of a limited n... IDXG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT